Effect of Urine-guided Hydration on Acute Kidney Injury After CRS-HIPEC

NACompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

July 24, 2023

Primary Completion Date

July 19, 2024

Study Completion Date

February 4, 2025

Conditions
Cytoreductive SurgeryHyperthermic Intraperitoneal ChemotherapyHydrationDiuresisAcute Kidney InjuryPostoperative Complications
Interventions
PROCEDURE

Urine-guided hydration

The target is to maintain urine output at 200 ml/h (3 ml/kg/h) or higher by intravenous injection/infusion of furosemide throughout surgery. That is, a loading dose of 20 mg is injected at the beginning of surgery; if urine output does not reach the target value, furosemide will be continuously infused at 10 mg/h until the end of surgery, with a cumulative dose not exceeding 250 mg. Intravenous rehydration is performed to balance urine output and to maintain the SVV ≤10%.

PROCEDURE

Routine hydration

The target is to maintain urine output at 0.5 ml/kg/h or higher according to routine practice. That is, furosemide is only administered when clinically necessary or at discretion of responsible anesthesiologists; intravenous rehydration is performed to maintain the SVV ≤10%.

DRUG

Forced administration of furosemide

Forced administration of furosemide

DRUG

Routine administration of furosemide

Routine administration of furosemide

Trial Locations (1)

100049

Aerospace Center Hospital, Beijing

All Listed Sponsors
collaborator

Aerospace Center Hospital

OTHER

lead

Peking University First Hospital

OTHER